ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Intranasal Drug and Vaccine Delivery Devices Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-38J14330
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Intranasal Drug and Vaccine Delivery Devices Market Research Report 2023
BUY CHAPTERS

Global Intranasal Drug and Vaccine Delivery Devices Market Research Report 2025

Code: QYRE-Auto-38J14330
Report
May 2025
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Teleflex
Intersect
Aptar Pharma
3M
Bespak
Teva Pharmaceuticals
GlaxoSmithKline PLC
OptiNose
UCB

Intranasal Drug and Vaccine Delivery Devices Market Size

The global market for Intranasal Drug and Vaccine Delivery Devices was valued at US$ 224 million in the year 2024 and is projected to reach a revised size of US$ 313 million by 2031, growing at a CAGR of 5.0% during the forecast period.

Intranasal Drug and Vaccine Delivery Devices Market

Intranasal Drug and Vaccine Delivery Devices Market

Delivery devices for intranasal drugs and vaccines
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Intranasal Drug and Vaccine Delivery Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intranasal Drug and Vaccine Delivery Devices.
The Intranasal Drug and Vaccine Delivery Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Intranasal Drug and Vaccine Delivery Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intranasal Drug and Vaccine Delivery Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Intranasal Drug and Vaccine Delivery Devices Market Report

Report Metric Details
Report Name Intranasal Drug and Vaccine Delivery Devices Market
Accounted market size in year US$ 224 million
Forecasted market size in 2031 US$ 313 million
CAGR 5.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Teva Pharmaceuticals, GlaxoSmithKline, Teleflex, Intersect, Aptar Pharma, 3M, OptiNose, UCB, Bespak
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Intranasal Drug and Vaccine Delivery Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Intranasal Drug and Vaccine Delivery Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Intranasal Drug and Vaccine Delivery Devices Market growing?

Ans: The Intranasal Drug and Vaccine Delivery Devices Market witnessing a CAGR of 5.0% during the forecast period 2025-2031.

What is the Intranasal Drug and Vaccine Delivery Devices Market size in 2031?

Ans: The Intranasal Drug and Vaccine Delivery Devices Market size in 2031 will be US$ 313 million.

Who are the main players in the Intranasal Drug and Vaccine Delivery Devices Market report?

Ans: The main players in the Intranasal Drug and Vaccine Delivery Devices Market are Teva Pharmaceuticals, GlaxoSmithKline, Teleflex, Intersect, Aptar Pharma, 3M, OptiNose, UCB, Bespak

What are the Application segmentation covered in the Intranasal Drug and Vaccine Delivery Devices Market report?

Ans: The Applications covered in the Intranasal Drug and Vaccine Delivery Devices Market report are Respiratory Diseases, Nervous System Disease, Vaccination, Pain Department, Other

What are the Type segmentation covered in the Intranasal Drug and Vaccine Delivery Devices Market report?

Ans: The Types covered in the Intranasal Drug and Vaccine Delivery Devices Market report are Powder Conveyor, Liquid Delivery Device, Pressurized Metered Dose Inhaler, Other

Recommended Reports

Nasal Drug Delivery

Drug Device Platforms

Therapeutics & Adjacent Devices

1 Intranasal Drug and Vaccine Delivery Devices Market Overview
1.1 Product Definition
1.2 Intranasal Drug and Vaccine Delivery Devices by Type
1.2.1 Global Intranasal Drug and Vaccine Delivery Devices Market Value Comparison by Type (2024 VS 2031)
1.2.2 Powder Conveyor
1.2.3 Liquid Delivery Device
1.2.4 Pressurized Metered Dose Inhaler
1.2.5 Other
1.3 Intranasal Drug and Vaccine Delivery Devices by Application
1.3.1 Global Intranasal Drug and Vaccine Delivery Devices Market Value by Application (2024 VS 2031)
1.3.2 Respiratory Diseases
1.3.3 Nervous System Disease
1.3.4 Vaccination
1.3.5 Pain Department
1.3.6 Other
1.4 Global Intranasal Drug and Vaccine Delivery Devices Market Size Estimates and Forecasts
1.4.1 Global Intranasal Drug and Vaccine Delivery Devices Revenue 2020-2031
1.4.2 Global Intranasal Drug and Vaccine Delivery Devices Sales 2020-2031
1.4.3 Global Intranasal Drug and Vaccine Delivery Devices Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Intranasal Drug and Vaccine Delivery Devices Market Competition by Manufacturers
2.1 Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Manufacturers (2020-2025)
2.2 Global Intranasal Drug and Vaccine Delivery Devices Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Intranasal Drug and Vaccine Delivery Devices Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Intranasal Drug and Vaccine Delivery Devices, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Intranasal Drug and Vaccine Delivery Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intranasal Drug and Vaccine Delivery Devices, Product Type & Application
2.7 Global Key Manufacturers of Intranasal Drug and Vaccine Delivery Devices, Date of Enter into This Industry
2.8 Global Intranasal Drug and Vaccine Delivery Devices Market Competitive Situation and Trends
2.8.1 Global Intranasal Drug and Vaccine Delivery Devices Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Intranasal Drug and Vaccine Delivery Devices Players Market Share by Revenue
2.8.3 Global Intranasal Drug and Vaccine Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Intranasal Drug and Vaccine Delivery Devices Market Scenario by Region
3.1 Global Intranasal Drug and Vaccine Delivery Devices Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Intranasal Drug and Vaccine Delivery Devices Sales by Region: 2020-2031
3.2.1 Global Intranasal Drug and Vaccine Delivery Devices Sales by Region: 2020-2025
3.2.2 Global Intranasal Drug and Vaccine Delivery Devices Sales by Region: 2026-2031
3.3 Global Intranasal Drug and Vaccine Delivery Devices Revenue by Region: 2020-2031
3.3.1 Global Intranasal Drug and Vaccine Delivery Devices Revenue by Region: 2020-2025
3.3.2 Global Intranasal Drug and Vaccine Delivery Devices Revenue by Region: 2026-2031
3.4 North America Intranasal Drug and Vaccine Delivery Devices Market Facts & Figures by Country
3.4.1 North America Intranasal Drug and Vaccine Delivery Devices Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Intranasal Drug and Vaccine Delivery Devices Sales by Country (2020-2031)
3.4.3 North America Intranasal Drug and Vaccine Delivery Devices Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Intranasal Drug and Vaccine Delivery Devices Market Facts & Figures by Country
3.5.1 Europe Intranasal Drug and Vaccine Delivery Devices Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Intranasal Drug and Vaccine Delivery Devices Sales by Country (2020-2031)
3.5.3 Europe Intranasal Drug and Vaccine Delivery Devices Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intranasal Drug and Vaccine Delivery Devices Market Facts & Figures by Region
3.6.1 Asia Pacific Intranasal Drug and Vaccine Delivery Devices Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Intranasal Drug and Vaccine Delivery Devices Sales by Region (2020-2031)
3.6.3 Asia Pacific Intranasal Drug and Vaccine Delivery Devices Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Intranasal Drug and Vaccine Delivery Devices Market Facts & Figures by Country
3.7.1 Latin America Intranasal Drug and Vaccine Delivery Devices Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Intranasal Drug and Vaccine Delivery Devices Sales by Country (2020-2031)
3.7.3 Latin America Intranasal Drug and Vaccine Delivery Devices Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Intranasal Drug and Vaccine Delivery Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Intranasal Drug and Vaccine Delivery Devices Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Intranasal Drug and Vaccine Delivery Devices Sales by Country (2020-2031)
3.8.3 Middle East and Africa Intranasal Drug and Vaccine Delivery Devices Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Intranasal Drug and Vaccine Delivery Devices Sales by Type (2020-2031)
4.1.1 Global Intranasal Drug and Vaccine Delivery Devices Sales by Type (2020-2025)
4.1.2 Global Intranasal Drug and Vaccine Delivery Devices Sales by Type (2026-2031)
4.1.3 Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Type (2020-2031)
4.2 Global Intranasal Drug and Vaccine Delivery Devices Revenue by Type (2020-2031)
4.2.1 Global Intranasal Drug and Vaccine Delivery Devices Revenue by Type (2020-2025)
4.2.2 Global Intranasal Drug and Vaccine Delivery Devices Revenue by Type (2026-2031)
4.2.3 Global Intranasal Drug and Vaccine Delivery Devices Revenue Market Share by Type (2020-2031)
4.3 Global Intranasal Drug and Vaccine Delivery Devices Price by Type (2020-2031)
5 Segment by Application
5.1 Global Intranasal Drug and Vaccine Delivery Devices Sales by Application (2020-2031)
5.1.1 Global Intranasal Drug and Vaccine Delivery Devices Sales by Application (2020-2025)
5.1.2 Global Intranasal Drug and Vaccine Delivery Devices Sales by Application (2026-2031)
5.1.3 Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Application (2020-2031)
5.2 Global Intranasal Drug and Vaccine Delivery Devices Revenue by Application (2020-2031)
5.2.1 Global Intranasal Drug and Vaccine Delivery Devices Revenue by Application (2020-2025)
5.2.2 Global Intranasal Drug and Vaccine Delivery Devices Revenue by Application (2026-2031)
5.2.3 Global Intranasal Drug and Vaccine Delivery Devices Revenue Market Share by Application (2020-2031)
5.3 Global Intranasal Drug and Vaccine Delivery Devices Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Teva Pharmaceuticals
6.1.1 Teva Pharmaceuticals Company Information
6.1.2 Teva Pharmaceuticals Description and Business Overview
6.1.3 Teva Pharmaceuticals Intranasal Drug and Vaccine Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Teva Pharmaceuticals Intranasal Drug and Vaccine Delivery Devices Product Portfolio
6.1.5 Teva Pharmaceuticals Recent Developments/Updates
6.2 GlaxoSmithKline
6.2.1 GlaxoSmithKline Company Information
6.2.2 GlaxoSmithKline Description and Business Overview
6.2.3 GlaxoSmithKline Intranasal Drug and Vaccine Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GlaxoSmithKline Intranasal Drug and Vaccine Delivery Devices Product Portfolio
6.2.5 GlaxoSmithKline Recent Developments/Updates
6.3 Teleflex
6.3.1 Teleflex Company Information
6.3.2 Teleflex Description and Business Overview
6.3.3 Teleflex Intranasal Drug and Vaccine Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Teleflex Intranasal Drug and Vaccine Delivery Devices Product Portfolio
6.3.5 Teleflex Recent Developments/Updates
6.4 Intersect
6.4.1 Intersect Company Information
6.4.2 Intersect Description and Business Overview
6.4.3 Intersect Intranasal Drug and Vaccine Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Intersect Intranasal Drug and Vaccine Delivery Devices Product Portfolio
6.4.5 Intersect Recent Developments/Updates
6.5 Aptar Pharma
6.5.1 Aptar Pharma Company Information
6.5.2 Aptar Pharma Description and Business Overview
6.5.3 Aptar Pharma Intranasal Drug and Vaccine Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Aptar Pharma Intranasal Drug and Vaccine Delivery Devices Product Portfolio
6.5.5 Aptar Pharma Recent Developments/Updates
6.6 3M
6.6.1 3M Company Information
6.6.2 3M Description and Business Overview
6.6.3 3M Intranasal Drug and Vaccine Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.6.4 3M Intranasal Drug and Vaccine Delivery Devices Product Portfolio
6.6.5 3M Recent Developments/Updates
6.7 OptiNose
6.7.1 OptiNose Company Information
6.7.2 OptiNose Description and Business Overview
6.7.3 OptiNose Intranasal Drug and Vaccine Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.7.4 OptiNose Intranasal Drug and Vaccine Delivery Devices Product Portfolio
6.7.5 OptiNose Recent Developments/Updates
6.8 UCB
6.8.1 UCB Company Information
6.8.2 UCB Description and Business Overview
6.8.3 UCB Intranasal Drug and Vaccine Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.8.4 UCB Intranasal Drug and Vaccine Delivery Devices Product Portfolio
6.8.5 UCB Recent Developments/Updates
6.9 Bespak
6.9.1 Bespak Company Information
6.9.2 Bespak Description and Business Overview
6.9.3 Bespak Intranasal Drug and Vaccine Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Bespak Intranasal Drug and Vaccine Delivery Devices Product Portfolio
6.9.5 Bespak Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intranasal Drug and Vaccine Delivery Devices Industry Chain Analysis
7.2 Intranasal Drug and Vaccine Delivery Devices Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intranasal Drug and Vaccine Delivery Devices Production Mode & Process Analysis
7.4 Intranasal Drug and Vaccine Delivery Devices Sales and Marketing
7.4.1 Intranasal Drug and Vaccine Delivery Devices Sales Channels
7.4.2 Intranasal Drug and Vaccine Delivery Devices Distributors
7.5 Intranasal Drug and Vaccine Delivery Devices Customer Analysis
8 Intranasal Drug and Vaccine Delivery Devices Market Dynamics
8.1 Intranasal Drug and Vaccine Delivery Devices Industry Trends
8.2 Intranasal Drug and Vaccine Delivery Devices Market Drivers
8.3 Intranasal Drug and Vaccine Delivery Devices Market Challenges
8.4 Intranasal Drug and Vaccine Delivery Devices Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Teleflex
Intersect
Aptar Pharma
3M
Bespak
Teva Pharmaceuticals
GlaxoSmithKline PLC
OptiNose
UCB
List of Tables
 Table 1. Global Intranasal Drug and Vaccine Delivery Devices Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Intranasal Drug and Vaccine Delivery Devices Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Intranasal Drug and Vaccine Delivery Devices Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Intranasal Drug and Vaccine Delivery Devices Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Intranasal Drug and Vaccine Delivery Devices Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Intranasal Drug and Vaccine Delivery Devices Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Intranasal Drug and Vaccine Delivery Devices Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Intranasal Drug and Vaccine Delivery Devices, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Intranasal Drug and Vaccine Delivery Devices, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Intranasal Drug and Vaccine Delivery Devices, Product Type & Application
 Table 12. Global Key Manufacturers of Intranasal Drug and Vaccine Delivery Devices, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Intranasal Drug and Vaccine Delivery Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intranasal Drug and Vaccine Delivery Devices as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Intranasal Drug and Vaccine Delivery Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Intranasal Drug and Vaccine Delivery Devices Sales by Region (2020-2025) & (K Units)
 Table 18. Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Region (2020-2025)
 Table 19. Global Intranasal Drug and Vaccine Delivery Devices Sales by Region (2026-2031) & (K Units)
 Table 20. Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Region (2026-2031)
 Table 21. Global Intranasal Drug and Vaccine Delivery Devices Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Intranasal Drug and Vaccine Delivery Devices Revenue Market Share by Region (2020-2025)
 Table 23. Global Intranasal Drug and Vaccine Delivery Devices Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Intranasal Drug and Vaccine Delivery Devices Revenue Market Share by Region (2026-2031)
 Table 25. North America Intranasal Drug and Vaccine Delivery Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Intranasal Drug and Vaccine Delivery Devices Sales by Country (2020-2025) & (K Units)
 Table 27. North America Intranasal Drug and Vaccine Delivery Devices Sales by Country (2026-2031) & (K Units)
 Table 28. North America Intranasal Drug and Vaccine Delivery Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Intranasal Drug and Vaccine Delivery Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Intranasal Drug and Vaccine Delivery Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Intranasal Drug and Vaccine Delivery Devices Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Intranasal Drug and Vaccine Delivery Devices Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Intranasal Drug and Vaccine Delivery Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Intranasal Drug and Vaccine Delivery Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Intranasal Drug and Vaccine Delivery Devices Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Intranasal Drug and Vaccine Delivery Devices Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Intranasal Drug and Vaccine Delivery Devices Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Intranasal Drug and Vaccine Delivery Devices Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Intranasal Drug and Vaccine Delivery Devices Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Intranasal Drug and Vaccine Delivery Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Intranasal Drug and Vaccine Delivery Devices Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Intranasal Drug and Vaccine Delivery Devices Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Intranasal Drug and Vaccine Delivery Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Intranasal Drug and Vaccine Delivery Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Intranasal Drug and Vaccine Delivery Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Intranasal Drug and Vaccine Delivery Devices Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Intranasal Drug and Vaccine Delivery Devices Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Intranasal Drug and Vaccine Delivery Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Intranasal Drug and Vaccine Delivery Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Intranasal Drug and Vaccine Delivery Devices Sales (K Units) by Type (2020-2025)
 Table 51. Global Intranasal Drug and Vaccine Delivery Devices Sales (K Units) by Type (2026-2031)
 Table 52. Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Type (2020-2025)
 Table 53. Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Type (2026-2031)
 Table 54. Global Intranasal Drug and Vaccine Delivery Devices Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Intranasal Drug and Vaccine Delivery Devices Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Intranasal Drug and Vaccine Delivery Devices Revenue Market Share by Type (2020-2025)
 Table 57. Global Intranasal Drug and Vaccine Delivery Devices Revenue Market Share by Type (2026-2031)
 Table 58. Global Intranasal Drug and Vaccine Delivery Devices Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Intranasal Drug and Vaccine Delivery Devices Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Intranasal Drug and Vaccine Delivery Devices Sales (K Units) by Application (2020-2025)
 Table 61. Global Intranasal Drug and Vaccine Delivery Devices Sales (K Units) by Application (2026-2031)
 Table 62. Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Application (2020-2025)
 Table 63. Global Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Application (2026-2031)
 Table 64. Global Intranasal Drug and Vaccine Delivery Devices Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Intranasal Drug and Vaccine Delivery Devices Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Intranasal Drug and Vaccine Delivery Devices Revenue Market Share by Application (2020-2025)
 Table 67. Global Intranasal Drug and Vaccine Delivery Devices Revenue Market Share by Application (2026-2031)
 Table 68. Global Intranasal Drug and Vaccine Delivery Devices Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Intranasal Drug and Vaccine Delivery Devices Price (US$/Unit) by Application (2026-2031)
 Table 70. Teva Pharmaceuticals Company Information
 Table 71. Teva Pharmaceuticals Description and Business Overview
 Table 72. Teva Pharmaceuticals Intranasal Drug and Vaccine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Teva Pharmaceuticals Intranasal Drug and Vaccine Delivery Devices Product
 Table 74. Teva Pharmaceuticals Recent Developments/Updates
 Table 75. GlaxoSmithKline Company Information
 Table 76. GlaxoSmithKline Description and Business Overview
 Table 77. GlaxoSmithKline Intranasal Drug and Vaccine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. GlaxoSmithKline Intranasal Drug and Vaccine Delivery Devices Product
 Table 79. GlaxoSmithKline Recent Developments/Updates
 Table 80. Teleflex Company Information
 Table 81. Teleflex Description and Business Overview
 Table 82. Teleflex Intranasal Drug and Vaccine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Teleflex Intranasal Drug and Vaccine Delivery Devices Product
 Table 84. Teleflex Recent Developments/Updates
 Table 85. Intersect Company Information
 Table 86. Intersect Description and Business Overview
 Table 87. Intersect Intranasal Drug and Vaccine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Intersect Intranasal Drug and Vaccine Delivery Devices Product
 Table 89. Intersect Recent Developments/Updates
 Table 90. Aptar Pharma Company Information
 Table 91. Aptar Pharma Description and Business Overview
 Table 92. Aptar Pharma Intranasal Drug and Vaccine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Aptar Pharma Intranasal Drug and Vaccine Delivery Devices Product
 Table 94. Aptar Pharma Recent Developments/Updates
 Table 95. 3M Company Information
 Table 96. 3M Description and Business Overview
 Table 97. 3M Intranasal Drug and Vaccine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. 3M Intranasal Drug and Vaccine Delivery Devices Product
 Table 99. 3M Recent Developments/Updates
 Table 100. OptiNose Company Information
 Table 101. OptiNose Description and Business Overview
 Table 102. OptiNose Intranasal Drug and Vaccine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. OptiNose Intranasal Drug and Vaccine Delivery Devices Product
 Table 104. OptiNose Recent Developments/Updates
 Table 105. UCB Company Information
 Table 106. UCB Description and Business Overview
 Table 107. UCB Intranasal Drug and Vaccine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. UCB Intranasal Drug and Vaccine Delivery Devices Product
 Table 109. UCB Recent Developments/Updates
 Table 110. Bespak Company Information
 Table 111. Bespak Description and Business Overview
 Table 112. Bespak Intranasal Drug and Vaccine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Bespak Intranasal Drug and Vaccine Delivery Devices Product
 Table 114. Bespak Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Intranasal Drug and Vaccine Delivery Devices Distributors List
 Table 118. Intranasal Drug and Vaccine Delivery Devices Customers List
 Table 119. Intranasal Drug and Vaccine Delivery Devices Market Trends
 Table 120. Intranasal Drug and Vaccine Delivery Devices Market Drivers
 Table 121. Intranasal Drug and Vaccine Delivery Devices Market Challenges
 Table 122. Intranasal Drug and Vaccine Delivery Devices Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Intranasal Drug and Vaccine Delivery Devices
 Figure 2. Global Intranasal Drug and Vaccine Delivery Devices Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Intranasal Drug and Vaccine Delivery Devices Market Share by Type: 2024 & 2031
 Figure 4. Powder Conveyor Product Picture
 Figure 5. Liquid Delivery Device Product Picture
 Figure 6. Pressurized Metered Dose Inhaler Product Picture
 Figure 7. Other Product Picture
 Figure 8. Global Intranasal Drug and Vaccine Delivery Devices Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Intranasal Drug and Vaccine Delivery Devices Market Share by Application: 2024 & 2031
 Figure 10. Respiratory Diseases
 Figure 11. Nervous System Disease
 Figure 12. Vaccination
 Figure 13. Pain Department
 Figure 14. Other
 Figure 15. Global Intranasal Drug and Vaccine Delivery Devices Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Intranasal Drug and Vaccine Delivery Devices Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Intranasal Drug and Vaccine Delivery Devices Sales (2020-2031) & (K Units)
 Figure 18. Global Intranasal Drug and Vaccine Delivery Devices Average Price (US$/Unit) & (2020-2031)
 Figure 19. Intranasal Drug and Vaccine Delivery Devices Report Years Considered
 Figure 20. Intranasal Drug and Vaccine Delivery Devices Sales Share by Manufacturers in 2024
 Figure 21. Global Intranasal Drug and Vaccine Delivery Devices Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Intranasal Drug and Vaccine Delivery Devices Players: Market Share by Revenue in Intranasal Drug and Vaccine Delivery Devices in 2024
 Figure 23. Intranasal Drug and Vaccine Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Intranasal Drug and Vaccine Delivery Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Country (2020-2031)
 Figure 26. North America Intranasal Drug and Vaccine Delivery Devices Revenue Market Share by Country (2020-2031)
 Figure 27. United States Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Country (2020-2031)
 Figure 30. Europe Intranasal Drug and Vaccine Delivery Devices Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Intranasal Drug and Vaccine Delivery Devices Revenue Market Share by Region (2020-2031)
 Figure 38. China Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. China Taiwan Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Southeast Asia Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Intranasal Drug and Vaccine Delivery Devices Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Intranasal Drug and Vaccine Delivery Devices Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Intranasal Drug and Vaccine Delivery Devices Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Intranasal Drug and Vaccine Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Intranasal Drug and Vaccine Delivery Devices by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Intranasal Drug and Vaccine Delivery Devices by Type (2020-2031)
 Figure 57. Global Intranasal Drug and Vaccine Delivery Devices Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Intranasal Drug and Vaccine Delivery Devices by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Intranasal Drug and Vaccine Delivery Devices by Application (2020-2031)
 Figure 60. Global Intranasal Drug and Vaccine Delivery Devices Price (US$/Unit) by Application (2020-2031)
 Figure 61. Intranasal Drug and Vaccine Delivery Devices Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Intranasal Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nasal Drug Delivery Technology Market Insights Forecast to 2030
Nasal Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nasal Polyps Treatment Market Insights Forecast to 2030
Bovine Medicine and Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Intranasal Drug And Vaccine Delivery Device Market Research Report 2024
Global Intranasal Drug Delivery Devices Market Insights Forecast to 2030
Veterinary Medicines and Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Technologies for Delivery of Proteins Antibodies and Nucleic Acids Market Insights Forecast to 2030
Global Pharmaceutical Drug Delivery Devices Market Insights Forecast to 2030
Bovine Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Drug Delivery in Cancer Market Insights Forecast to 2030
Diagnostic ENT Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Glass Bottle for Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharmaceutical Drug Delivery Technologies Market Insights Forecast to 2030
Intranasal Drug Delivery System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Colon Targeted Drug Delivery Systems Market Insights Forecast to 2030
Novel Vaccine Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Farm Animals Medicines and Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Rheumatic Disorders Drug Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions